 | • レポートコード：MRC23Q36474 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のアセチルシステイン注射市場について調査・分析し、世界のアセチルシステイン注射市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（4g/20ml、6g/30ml）、用途別セグメント分析（アセトアミノフェン過剰摂取治療、肝不全早期治療）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Ethypharm、Cumberland Pharmaceuticals、Akorn、Pfizer、AuroMedics Pharma、Sagent Pharmaceuticals、Zambon Spa、Perrigo、Samarth Life Sciences、Novartis、Fresenius Kabi、APP Pharmaceuticals、Paddock Laboratories、Padagis、Teligent Ou、Minsheng Pharmaceuticalなどが含まれています。世界のアセチルシステイン注射市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、アセチルシステイン注射市場規模を推定する際に考慮しました。本レポートは、アセチルシステイン注射の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、アセチルシステイン注射に関するビジネス上の意思決定に役立てることを目的としています。 ・アセチルシステイン注射市場の概要 - 製品の定義 - アセチルシステイン注射のタイプ別セグメント - 世界のアセチルシステイン注射市場規模：タイプ別分析（4g/20ml、6g/30ml） - アセチルシステイン注射の用途別セグメント - 世界のアセチルシステイン注射市場規模：用途別分析（アセトアミノフェン過剰摂取治療、肝不全早期治療） - 世界のアセチルシステイン注射市場規模予測（2018年-2029年） - アセチルシステイン注射の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - アセチルシステイン注射市場の競争状況およびトレンド ・アセチルシステイン注射の地域別市場規模 - 北米のアセチルシステイン注射市場規模（2018年-2029年） - アメリカのアセチルシステイン注射市場規模（2018年-2029年） - ヨーロッパのアセチルシステイン注射市場規模（2018年-2029年） - アジア太平洋のアセチルシステイン注射市場規模（2018年-2029年） - 中国のアセチルシステイン注射市場規模（2018年-2029年） - 日本のアセチルシステイン注射市場規模（2018年-2029年） - 韓国のアセチルシステイン注射市場規模（2018年-2029年） - インドのアセチルシステイン注射市場規模（2018年-2029年） - オーストラリアのアセチルシステイン注射市場規模（2018年-2029年） - 中南米のアセチルシステイン注射市場規模（2018年-2029年） - 中東・アフリカのアセチルシステイン注射市場規模（2018年-2029年） ・タイプ別セグメント：4g/20ml、6g/30ml - 世界のアセチルシステイン注射のタイプ別販売量（2018年-2023年） - 世界のアセチルシステイン注射のタイプ別売上（2018年-2023年） - 世界のアセチルシステイン注射のタイプ別価格 ・用途別セグメント：アセトアミノフェン過剰摂取治療、肝不全早期治療 - 世界のアセチルシステイン注射の用途別販売量（2018年-2023年） - 世界のアセチルシステイン注射の用途別売上（2018年-2023年） - 世界のアセチルシステイン注射の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Ethypharm、Cumberland Pharmaceuticals、Akorn、Pfizer、AuroMedics Pharma、Sagent Pharmaceuticals、Zambon Spa、Perrigo、Samarth Life Sciences、Novartis、Fresenius Kabi、APP Pharmaceuticals、Paddock Laboratories、Padagis、Teligent Ou、Minsheng Pharmaceutical ・産業チェーンと販売チャネルの分析 - アセチルシステイン注射産業チェーン分析 - アセチルシステイン注射の主要原材料 - アセチルシステイン注射の販売チャネル - アセチルシステイン注射のディストリビューター - アセチルシステイン注射の主要顧客 ・アセチルシステイン注射市場ダイナミクス - アセチルシステイン注射の業界動向 - アセチルシステイン注射市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Acetylcysteine Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Acetylcysteine Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Acetylcysteine Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Acetylcysteine Injection include Ethypharm, Cumberland Pharmaceuticals, Akorn, Pfizer, AuroMedics Pharma, Sagent Pharmaceuticals, Zambon Spa, Perrigo and Samarth Life Sciences, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Acetylcysteine Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acetylcysteine Injection.
The Acetylcysteine Injection market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Acetylcysteine Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acetylcysteine Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Ethypharm
Cumberland Pharmaceuticals
Akorn
Pfizer
AuroMedics Pharma
Sagent Pharmaceuticals
Zambon Spa
Perrigo
Samarth Life Sciences
Novartis
Fresenius Kabi
APP Pharmaceuticals
Paddock Laboratories
Padagis
Teligent Ou
Minsheng Pharmaceutical
Segment by Type
4g/20ml
6g/30ml
Segment by Application
Treating Acetaminophen Overdose
Early Treatment of Liver Failure
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acetylcysteine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acetylcysteine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Acetylcysteine Injection Market Overview
1.1 Product Overview and Scope of Acetylcysteine Injection
1.2 Acetylcysteine Injection Segment by Type
1.2.1 Global Acetylcysteine Injection Market Value Comparison by Type (2023-2029)
1.2.2 4g/20ml
1.2.3 6g/30ml
1.3 Acetylcysteine Injection Segment by Application
1.3.1 Global Acetylcysteine Injection Market Value by Application: (2023-2029)
1.3.2 Treating Acetaminophen Overdose
1.3.3 Early Treatment of Liver Failure
1.4 Global Acetylcysteine Injection Market Size Estimates and Forecasts
1.4.1 Global Acetylcysteine Injection Revenue 2018-2029
1.4.2 Global Acetylcysteine Injection Sales 2018-2029
1.4.3 Global Acetylcysteine Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Acetylcysteine Injection Market Competition by Manufacturers
2.1 Global Acetylcysteine Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Acetylcysteine Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Acetylcysteine Injection Average Price by Manufacturers (2018-2023)
2.4 Global Acetylcysteine Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Acetylcysteine Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Acetylcysteine Injection, Product Type & Application
2.7 Acetylcysteine Injection Market Competitive Situation and Trends
2.7.1 Acetylcysteine Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Acetylcysteine Injection Players Market Share by Revenue
2.7.3 Global Acetylcysteine Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Acetylcysteine Injection Retrospective Market Scenario by Region
3.1 Global Acetylcysteine Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Acetylcysteine Injection Global Acetylcysteine Injection Sales by Region: 2018-2029
3.2.1 Global Acetylcysteine Injection Sales by Region: 2018-2023
3.2.2 Global Acetylcysteine Injection Sales by Region: 2024-2029
3.3 Global Acetylcysteine Injection Global Acetylcysteine Injection Revenue by Region: 2018-2029
3.3.1 Global Acetylcysteine Injection Revenue by Region: 2018-2023
3.3.2 Global Acetylcysteine Injection Revenue by Region: 2024-2029
3.4 North America Acetylcysteine Injection Market Facts & Figures by Country
3.4.1 North America Acetylcysteine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Acetylcysteine Injection Sales by Country (2018-2029)
3.4.3 North America Acetylcysteine Injection Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Acetylcysteine Injection Market Facts & Figures by Country
3.5.1 Europe Acetylcysteine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Acetylcysteine Injection Sales by Country (2018-2029)
3.5.3 Europe Acetylcysteine Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Acetylcysteine Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Acetylcysteine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Acetylcysteine Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Acetylcysteine Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Acetylcysteine Injection Market Facts & Figures by Country
3.7.1 Latin America Acetylcysteine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Acetylcysteine Injection Sales by Country (2018-2029)
3.7.3 Latin America Acetylcysteine Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Acetylcysteine Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Acetylcysteine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Acetylcysteine Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Acetylcysteine Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Acetylcysteine Injection Sales by Type (2018-2029)
4.1.1 Global Acetylcysteine Injection Sales by Type (2018-2023)
4.1.2 Global Acetylcysteine Injection Sales by Type (2024-2029)
4.1.3 Global Acetylcysteine Injection Sales Market Share by Type (2018-2029)
4.2 Global Acetylcysteine Injection Revenue by Type (2018-2029)
4.2.1 Global Acetylcysteine Injection Revenue by Type (2018-2023)
4.2.2 Global Acetylcysteine Injection Revenue by Type (2024-2029)
4.2.3 Global Acetylcysteine Injection Revenue Market Share by Type (2018-2029)
4.3 Global Acetylcysteine Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Acetylcysteine Injection Sales by Application (2018-2029)
5.1.1 Global Acetylcysteine Injection Sales by Application (2018-2023)
5.1.2 Global Acetylcysteine Injection Sales by Application (2024-2029)
5.1.3 Global Acetylcysteine Injection Sales Market Share by Application (2018-2029)
5.2 Global Acetylcysteine Injection Revenue by Application (2018-2029)
5.2.1 Global Acetylcysteine Injection Revenue by Application (2018-2023)
5.2.2 Global Acetylcysteine Injection Revenue by Application (2024-2029)
5.2.3 Global Acetylcysteine Injection Revenue Market Share by Application (2018-2029)
5.3 Global Acetylcysteine Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Ethypharm
6.1.1 Ethypharm Corporation Information
6.1.2 Ethypharm Description and Business Overview
6.1.3 Ethypharm Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Ethypharm Acetylcysteine Injection Product Portfolio
6.1.5 Ethypharm Recent Developments/Updates
6.2 Cumberland Pharmaceuticals
6.2.1 Cumberland Pharmaceuticals Corporation Information
6.2.2 Cumberland Pharmaceuticals Description and Business Overview
6.2.3 Cumberland Pharmaceuticals Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Cumberland Pharmaceuticals Acetylcysteine Injection Product Portfolio
6.2.5 Cumberland Pharmaceuticals Recent Developments/Updates
6.3 Akorn
6.3.1 Akorn Corporation Information
6.3.2 Akorn Description and Business Overview
6.3.3 Akorn Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Akorn Acetylcysteine Injection Product Portfolio
6.3.5 Akorn Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Acetylcysteine Injection Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 AuroMedics Pharma
6.5.1 AuroMedics Pharma Corporation Information
6.5.2 AuroMedics Pharma Description and Business Overview
6.5.3 AuroMedics Pharma Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 AuroMedics Pharma Acetylcysteine Injection Product Portfolio
6.5.5 AuroMedics Pharma Recent Developments/Updates
6.6 Sagent Pharmaceuticals
6.6.1 Sagent Pharmaceuticals Corporation Information
6.6.2 Sagent Pharmaceuticals Description and Business Overview
6.6.3 Sagent Pharmaceuticals Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sagent Pharmaceuticals Acetylcysteine Injection Product Portfolio
6.6.5 Sagent Pharmaceuticals Recent Developments/Updates
6.7 Zambon Spa
6.6.1 Zambon Spa Corporation Information
6.6.2 Zambon Spa Description and Business Overview
6.6.3 Zambon Spa Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zambon Spa Acetylcysteine Injection Product Portfolio
6.7.5 Zambon Spa Recent Developments/Updates
6.8 Perrigo
6.8.1 Perrigo Corporation Information
6.8.2 Perrigo Description and Business Overview
6.8.3 Perrigo Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Perrigo Acetylcysteine Injection Product Portfolio
6.8.5 Perrigo Recent Developments/Updates
6.9 Samarth Life Sciences
6.9.1 Samarth Life Sciences Corporation Information
6.9.2 Samarth Life Sciences Description and Business Overview
6.9.3 Samarth Life Sciences Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Samarth Life Sciences Acetylcysteine Injection Product Portfolio
6.9.5 Samarth Life Sciences Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Novartis Acetylcysteine Injection Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Fresenius Kabi
6.11.1 Fresenius Kabi Corporation Information
6.11.2 Fresenius Kabi Acetylcysteine Injection Description and Business Overview
6.11.3 Fresenius Kabi Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Fresenius Kabi Acetylcysteine Injection Product Portfolio
6.11.5 Fresenius Kabi Recent Developments/Updates
6.12 APP Pharmaceuticals
6.12.1 APP Pharmaceuticals Corporation Information
6.12.2 APP Pharmaceuticals Acetylcysteine Injection Description and Business Overview
6.12.3 APP Pharmaceuticals Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 APP Pharmaceuticals Acetylcysteine Injection Product Portfolio
6.12.5 APP Pharmaceuticals Recent Developments/Updates
6.13 Paddock Laboratories
6.13.1 Paddock Laboratories Corporation Information
6.13.2 Paddock Laboratories Acetylcysteine Injection Description and Business Overview
6.13.3 Paddock Laboratories Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Paddock Laboratories Acetylcysteine Injection Product Portfolio
6.13.5 Paddock Laboratories Recent Developments/Updates
6.14 Padagis
6.14.1 Padagis Corporation Information
6.14.2 Padagis Acetylcysteine Injection Description and Business Overview
6.14.3 Padagis Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Padagis Acetylcysteine Injection Product Portfolio
6.14.5 Padagis Recent Developments/Updates
6.15 Teligent Ou
6.15.1 Teligent Ou Corporation Information
6.15.2 Teligent Ou Acetylcysteine Injection Description and Business Overview
6.15.3 Teligent Ou Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Teligent Ou Acetylcysteine Injection Product Portfolio
6.15.5 Teligent Ou Recent Developments/Updates
6.16 Minsheng Pharmaceutical
6.16.1 Minsheng Pharmaceutical Corporation Information
6.16.2 Minsheng Pharmaceutical Acetylcysteine Injection Description and Business Overview
6.16.3 Minsheng Pharmaceutical Acetylcysteine Injection Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Minsheng Pharmaceutical Acetylcysteine Injection Product Portfolio
6.16.5 Minsheng Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Acetylcysteine Injection Industry Chain Analysis
7.2 Acetylcysteine Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Acetylcysteine Injection Production Mode & Process
7.4 Acetylcysteine Injection Sales and Marketing
7.4.1 Acetylcysteine Injection Sales Channels
7.4.2 Acetylcysteine Injection Distributors
7.5 Acetylcysteine Injection Customers
8 Acetylcysteine Injection Market Dynamics
8.1 Acetylcysteine Injection Industry Trends
8.2 Acetylcysteine Injection Market Drivers
8.3 Acetylcysteine Injection Market Challenges
8.4 Acetylcysteine Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
